Engineered nanoparticles of Efavirenz using methacrylate co-polymer (Eudragit-E100) and its biological effects in-vivo

Article ID	Journal	Published Year	Pages	File Type
7867283	Materials Science and Engineering: C	2016	42 Pages	PDF

Keywords

PDI Eudragit E100 FDA CPCSEA CC50 NRTIs Emtricitabine 3TC CD4 RES RDS HAART FTC LC-MS-MS PIS FE-SEM FBS CAF AUC MTT MTT assay enzyme linked immunosorbent assay internal standard AIDS HIV/AIDS analysis of variance ELISA Biodistribution maximum plasma concentration cluster of differentiation Antiretroviral therapy Highly active anti-retroviral therapy CNS BCs Food and Drug Administration BBB blood brain barrier sodium dodecyl sulfate fetal bovine serum Biopharmaceutical classification system central nervous system polydispersity index Lamivudine Roswell Park Memorial Institute area under the curve Nucleoside reverse transcriptase inhibitors Protease inhibitors Field emission scanning electron microscopy Nanoparticle ART HIV human immunodeficiency virus high performance liquid chromatography HPLC Committee for the Purpose of Control and Supervision of Experiments on Animals Rate-determining Step

Related Topics

Physical Sciences and Engineering Materials Science Biomaterials

Engineered nanoparticles of Efavirenz using methacrylate co-polymer (Eudragit-E100) and its biological effects in-vivo

Authors

B.N. Vedha Hari, N. Narayanan, K. Dhevendaran, D. Ramyadevi,